This list is an analysis based on recent market events. It's not an investment recommendation.
Respiratorius AB (publ), a research company, develops pharmaceuticals for the treatment of cancer. The company's products under development include VAL001, that is in Phase III clinical trials for the treatment of diffuse large B-cell lymphoma; and VAL001, a product candidate that is in preclinical phase for the treatment of relapsing diffuse large B-cell lymphoma. Respiratorius AB (publ) was incorporated in 1998 and is based in Lund, Sweden.
FAQs
What is Respiratorius AB stock price today?▼
The current price of RESP.ST is SEK2.17 SEK — it has increased by +5.85% in the past 24 hours. Watch Respiratorius AB stock price performance more closely on the chart.
What is Respiratorius AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Respiratorius AB stocks are traded under the ticker RESP.ST.
Is Respiratorius AB stock price growing?▼
RESP.ST stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Respiratorius AB has showed a +6.37% increase.
What is Respiratorius AB market cap?▼
Today Respiratorius AB has the market capitalization of 17.15M
What is Respiratorius AB revenue for the last year?▼
Respiratorius AB revenue for the last year amounts to 0 SEK.
What is Respiratorius AB net income for the last year?▼
RESP.ST net income for the last year is -6.95M SEK.
In which sector is Respiratorius AB located?▼
Respiratorius AB operates in the Real Estate sector.
When did Respiratorius AB complete a stock split?▼
The last stock split for Respiratorius AB was on November 27, 2024 with a ratio of 1:100.
Where is Respiratorius AB headquartered?▼
Respiratorius AB is headquartered in Lund, Sweden.